Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
Giovanni Musso(Ospedale San Luigi Gonzaga), Roberto Gambino(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 666
Related Papers
Inhibition of leukocyte-endothelial cell interactions and inflammation by peptides from a bacterial adhesin which mimic coagulation factor X.
|Journal of Clinical Investigation|1995|35